The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis

Studies to confirm the effect of acknowledged prognostic markers in older breast cancer patients are scarce. The aim of this study was to evaluate the prognostic value of HER-2 overexpression and PIK3CA mutations in older breast cancer patients. Female breast cancer patients aged 65 years or older,...

Descripción completa

Detalles Bibliográficos
Autores principales: Engels, Charla C., Kiderlen, Mandy, Bastiaannet, Esther, van Eijk, Ronald, Mooyaart, Antien, Smit, Vincent T. H. B. M., de Craen, Anton J. M., Kuppen, Peter J. K., Kroep, Judith R., van de Velde, Cornelis J. H., Liefers, Gerrit Jan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819549/
https://www.ncbi.nlm.nih.gov/pubmed/26968397
http://dx.doi.org/10.1007/s10549-016-3734-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819549/
https://www.ncbi.nlm.nih.gov/pubmed/26968397
http://dx.doi.org/10.1007/s10549-016-3734-y

Ejemplares similares